| Year |
Citation |
Score |
| 2024 |
Zhang T, Wang X, Jester HM, Zhou X, Ma T. Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome. Journal of Alzheimer's Disease : Jad. PMID 39302375 DOI: 10.3233/JAD-240675 |
0.757 |
|
| 2024 |
Swift NA, Yang Q, Jester HM, Zhou X, Manuel A, Kemp BE, Steinberg GR, Ma T. Suppression of neuronal AMPKβ2 isoform impairs recognition memory and synaptic plasticity. Neurobiology of Disease. 201: 106664. PMID 39278510 DOI: 10.1016/j.nbd.2024.106664 |
0.762 |
|
| 2024 |
Wang X, Yang Q, Zhou X, Keene CD, Ryazanov AG, Ma T. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38934363 DOI: 10.1002/alz.13916 |
0.311 |
|
| 2024 |
Yang Q, Zhou X, Ma T. Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease. Neurobiology of Aging. 140: 116-121. PMID 38763076 DOI: 10.1016/j.neurobiolaging.2024.05.009 |
0.527 |
|
| 2023 |
Zhao B, Wei D, Long Q, Chen Q, Wang F, Chen L, Li Z, Li T, Ma T, Liu W, Wang L, Yang C, Zhang X, Wang P, Zhang Z. Altered synaptic currents, mitophagy, mitochondrial dynamics in Alzheimer's disease models and therapeutic potential of Dengzhan Shengmai capsules intervention. Journal of Pharmaceutical Analysis. 14: 348-370. PMID 38618251 DOI: 10.1016/j.jpha.2023.10.006 |
0.324 |
|
| 2023 |
Zhou X, Yang W, Wang X, Ma T. Isoform-specific effects of neuronal repression of the AMPK catalytic subunit on cognitive function in aged mice. Aging. 15: 932-946. PMID 36842095 DOI: 10.18632/aging.204554 |
0.385 |
|
| 2023 |
Wang X, Zhou X, Lee J, Furdui CM, Ma T. In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36641677 DOI: 10.3233/JAD-221044 |
0.42 |
|
| 2022 |
Kasica NP, Zhou X, Jester HM, Holland CE, Ryazanov AG, Forshaw TE, Furdui CM, Ma T. Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer's disease model mice independent of brain amyloid β pathology. Frontiers in Aging Neuroscience. 14: 959326. PMID 36158543 DOI: 10.3389/fnagi.2022.959326 |
0.821 |
|
| 2022 |
Jester H, Gosrani S, Ding H, Zhou X, Ko MC, Ma T. Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 35723096 DOI: 10.3233/JAD-215303 |
0.763 |
|
| 2022 |
Liu L, Dai WZ, Zhu XC, Ma T. A review of autophagy mechanism of statins in the potential therapy of Alzheimer's disease. Journal of Integrative Neuroscience. 21: 46. PMID 35364634 DOI: 10.31083/j.jin2102046 |
0.322 |
|
| 2022 |
Guo C, Wen D, Zhang Y, Mustaklem R, Mustaklem B, Zhou M, Ma T, Ma YY. Amyloid-β oligomers in the nucleus accumbens decrease motivation via insertion of calcium-permeable AMPA receptors. Molecular Psychiatry. PMID 35105968 DOI: 10.1038/s41380-022-01459-0 |
0.376 |
|
| 2022 |
Zhu XC, Liu L, Dai WZ, Ma T. Crry silencing alleviates Alzheimer's disease injury by regulating neuroinflammatory cytokines and the complement system. Neural Regeneration Research. 17: 1841-1849. PMID 35017447 DOI: 10.4103/1673-5374.332160 |
0.324 |
|
| 2021 |
Kasica NP, Zhou X, Yang Q, Wang X, Yang W, Zimmermann HR, Holland CE, Koscielniak E, Wu H, Cox AO, Lee J, Ryazanov AG, Furdui CM, Ma T. Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice. Journal of Neurochemistry. PMID 34932218 DOI: 10.1111/jnc.15562 |
0.418 |
|
| 2021 |
Ma T. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer's disease. Journal of Neurochemistry. PMID 34796967 DOI: 10.1111/jnc.15541 |
0.357 |
|
| 2021 |
Wang X, Zhou X, Uberseder B, Lee J, Latimer CS, Furdui CM, Keene CD, Montine TJ, Register TC, Craft S, Shively CA, Ma T. Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease. Neurobiology of Disease. 105463. PMID 34363967 DOI: 10.1016/j.nbd.2021.105463 |
0.302 |
|
| 2021 |
Oliveira MM, Lourenco MV, Longo F, Kasica NP, Yang W, Ureta G, Ferreira DDP, Mendonça PHJ, Bernales S, Ma T, De Felice FG, Klann E, Ferreira ST. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer's disease. Science Signaling. 14. PMID 33531382 DOI: 10.1126/scisignal.abc5429 |
0.776 |
|
| 2020 |
Yang W, Zhou X, Ryazanov AG, Ma T. Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Neurobiology of Aging. 98: 225-230. PMID 33341653 DOI: 10.1016/j.neurobiolaging.2020.11.016 |
0.45 |
|
| 2020 |
Gosrani SP, Jester HM, Zhou X, Ryazanov AG, Ma T. Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice. Neurobiology of Aging. 95: 154-160. PMID 32810756 DOI: 10.1016/J.Neurobiolaging.2020.07.016 |
0.785 |
|
| 2020 |
Wang X, Zimmermann HR, Lockhart SN, Craft S, Ma T. Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 32444538 DOI: 10.3233/Jad-191189 |
0.415 |
|
| 2020 |
Yang W, Zhou X, Zimmermann HR, Ma T. Brain-specific suppression of AMPKα2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2α phosphorylation. Molecular Psychiatry. PMID 32366952 DOI: 10.1038/S41380-020-0739-Z |
0.479 |
|
| 2020 |
Zimmermann HR, Yang W, Kasica NP, Zhou X, Wang X, Beckelman BC, Lee J, Furdui CM, Keene CD, Ma T. Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice. The Journal of Clinical Investigation. PMID 32213711 DOI: 10.1172/Jci133982 |
0.452 |
|
| 2019 |
Yang W, Zhou X, Ma T. Memory Decline and Behavioral Inflexibility in Aged Mice Are Correlated With Dysregulation of Protein Synthesis Capacity. Frontiers in Aging Neuroscience. 11: 246. PMID 31551760 DOI: 10.3389/Fnagi.2019.00246 |
0.506 |
|
| 2019 |
Day SM, Ma T. Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease. Neuroscience Bulletin. PMID 30843143 DOI: 10.1007/S12264-019-00355-Y |
0.305 |
|
| 2019 |
Wang X, Zimmermann HR, Ma T. Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30776001 DOI: 10.3233/Jad-181043 |
0.511 |
|
| 2019 |
Beckelman BC, Yang W, Kasica NP, Zimmermann HR, Zhou X, Keene CD, Ryazanov AG, Ma T. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice. The Journal of Clinical Investigation. PMID 30667373 DOI: 10.1172/Jci122954 |
0.535 |
|
| 2019 |
Uneri A, Niere F, Craft S, Keene DC, Ma T, Raab-Graham KF. P1-180: ABNORMAL DJ-1 EXPRESSION IN ALZHEIMER'S DISEASE AND ITS IMPACT ON SYNAPTIC MRNA TRANSLATION AND FUNCTION Alzheimer's & Dementia. 15: P305-P305. DOI: 10.1016/J.Jalz.2019.06.735 |
0.424 |
|
| 2018 |
Zimmermann HR, Yang W, Beckelman BC, Kasica NP, Zhou X, Galli L, Ryazanov AG, Ma T. Genetic Removal of eIF2α Kinase PERK in Mice Enables Hippocampal L-LTP Independent of mTORC1 Activity. Journal of Neurochemistry. PMID 29337352 DOI: 10.1111/Jnc.14306 |
0.502 |
|
| 2017 |
Day SM, Yang W, Ewin S, Zhou X, Ma T. Glucagon-Like Peptide-1 Cleavage Product GLP-1 (9-36) Amide Enhances Hippocampal Long-term Synaptic Plasticity in Correlation with Suppression of Kv4.2 expression and eEF2 Phosphorylation. Hippocampus. PMID 28833775 DOI: 10.1002/Hipo.22795 |
0.452 |
|
| 2017 |
Zimmermann HR, Zhou X, Ma T. [P1-217]: AMPK ISOFORM HOMEOSTASIS DYSREGULATION IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P326-P326. DOI: 10.1016/J.Jalz.2017.06.037 |
0.331 |
|
| 2016 |
Beckelman BC, Day S, Zhou X, Donohue M, Gouras GK, Klann E, Keene CD, Ma T. Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27567813 DOI: 10.3233/Jad-160036 |
0.79 |
|
| 2016 |
Yang W, Zhou X, Zimmermann HR, Cavener DR, Klann E, Ma T. Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Neurobiology of Aging. 41: 19-24. PMID 27103515 DOI: 10.1016/J.Neurobiolaging.2016.02.005 |
0.724 |
|
| 2015 |
Beckelman BC, Zhou X, Keene CD, Ma T. Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease. Neuro-Degenerative Diseases. PMID 26551858 DOI: 10.1159/000438925 |
0.353 |
|
| 2015 |
Lan YL, Zhao J, Ma T, Li S. The Potential Roles of Aquaporin 4 in Alzheimer's Disease. Molecular Neurobiology. PMID 26433375 DOI: 10.1007/s12035-015-9446-1 |
0.311 |
|
| 2015 |
Tan XL, Xue YQ, Ma T, Wang X, Li JJ, Lan L, Malik KU, McDonald MP, Dopico AM, Liao FF. Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Molecular Neurodegeneration. 10: 24. PMID 26104027 DOI: 10.1186/S13024-015-0020-0 |
0.333 |
|
| 2015 |
Li R, Xu DE, Ma T. Lovastatin suppresses the aberrant tau phosphorylation from FTDP-17 mutation and okadaic acid-induction in rat primary neurons. Neuroscience. 294: 14-20. PMID 25770969 DOI: 10.1016/J.Neuroscience.2015.03.005 |
0.319 |
|
| 2014 |
Ma T, Chen Y, Vingtdeux V, Zhao H, Viollet B, Marambaud P, Klann E. Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12230-8. PMID 25186765 DOI: 10.1523/Jneurosci.1694-14.2014 |
0.797 |
|
| 2014 |
Ma T, Klann E. PERK: a novel therapeutic target for neurodegenerative diseases? Alzheimer's Research & Therapy. 6: 30. PMID 25031640 DOI: 10.1186/Alzrt260 |
0.59 |
|
| 2014 |
Trinh MA, Ma T, Kaphzan H, Bhattacharya A, Antion MD, Cavener DR, Hoeffer CA, Klann E. The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression. Learning & Memory (Cold Spring Harbor, N.Y.). 21: 298-304. PMID 24741110 DOI: 10.1101/Lm.032219.113 |
0.737 |
|
| 2014 |
Kurinami H, Shimamura M, Ma T, Qian L, Koizumi K, Park L, Klann E, Manfredi G, Iadecola C, Zhou P. Prohibitin viral gene transfer protects hippocampal CA1 neurons from ischemia and ameliorates postischemic hippocampal dysfunction. Stroke; a Journal of Cerebral Circulation. 45: 1131-8. PMID 24619393 DOI: 10.1161/Strokeaha.113.003577 |
0.557 |
|
| 2014 |
Dong W, Wang X, Bi S, Pan Z, Liu S, Yu H, Lu H, Lin X, Wang X, Ma T, Zhang W. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. International Journal of Molecular Medicine. 33: 1161-8. PMID 24584901 DOI: 10.3892/Ijmm.2014.1680 |
0.304 |
|
| 2014 |
Ma T. GSK3 in Alzheimer's disease: mind the isoforms. Journal of Alzheimer's Disease : Jad. 39: 707-10. PMID 24254703 DOI: 10.3233/Jad-131661 |
0.416 |
|
| 2013 |
Ma T, Trinh MA, Wexler AJ, Bourbon C, Gatti E, Pierre P, Cavener DR, Klann E. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nature Neuroscience. 16: 1299-305. PMID 23933749 DOI: 10.1038/Nn.3486 |
0.793 |
|
| 2013 |
Hoeffer CA, Santini E, Ma T, Arnold EC, Whelan AM, Wong H, Pierre P, Pelletier J, Klann E. Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation. Journal of Neurophysiology. 109: 68-76. PMID 23054596 DOI: 10.1152/Jn.00342.2012 |
0.688 |
|
| 2013 |
Ma T, Klann E. O3-02-01: Reversal of synaptic plasticity and spatial memory deficits in APP/PS1 mice by suppressing protein kinase GCN2 Alzheimer's & Dementia. 9: P519-P520. DOI: 10.1016/J.Jalz.2013.04.242 |
0.667 |
|
| 2012 |
Ma T, Du X, Pick JE, Sui G, Brownlee M, Klann E. Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 13701-8. PMID 23035082 DOI: 10.1523/Jneurosci.2107-12.2012 |
0.755 |
|
| 2012 |
Ma T, Shrestha PL, Hempel M, Peng D, Sharif H, Chen HH. Assurance of energy efficiency and data security for ECG transmission in BASNs. Ieee Transactions On Bio-Medical Engineering. 59: 1041-8. PMID 22231147 DOI: 10.1109/Tbme.2011.2182196 |
0.37 |
|
| 2012 |
Ma T, Klann E. Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease. Journal of Neurochemistry. 120: 140-8. PMID 22122128 DOI: 10.1111/J.1471-4159.2011.07506.X |
0.687 |
|
| 2012 |
Ma T. O5-01-06: Repression of eIF2α phosphorylation via conditional deletion of PERK alleviates synaptic plasticity and spatial memory impairments in APP/PS1 mice Alzheimer's & Dementia. 8: P730-P731. DOI: 10.1016/j.jalz.2012.05.1974 |
0.337 |
|
| 2011 |
Ma T, Tzavaras N, Tsokas P, Landau EM, Blitzer RD. Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3 Journal of Neuroscience. 31: 17537-17546. PMID 22131415 DOI: 10.1523/Jneurosci.4761-11.2011 |
0.815 |
|
| 2011 |
Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C, Murphy MP, Pautler RG, Klann E. Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5589-95. PMID 21490199 DOI: 10.1523/Jneurosci.6566-10.2011 |
0.792 |
|
| 2010 |
Kwak YD, Ma T, Diao S, Zhang X, Chen Y, Hsu J, Lipton SA, Masliah E, Xu H, Liao FF. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Molecular Neurodegeneration. 5: 49. PMID 21067594 DOI: 10.1186/1750-1326-5-49 |
0.39 |
|
| 2010 |
Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H, Lin MT, Tampellini D, Klann E, Blitzer RD, Gouras GK. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. Plos One. 5. PMID 20862226 DOI: 10.1371/Journal.Pone.0012845 |
0.817 |
|
| 2009 |
Ma T, Zhao Y, Kwak YD, Yang Z, Thompson R, Luo Z, Xu H, Liao FF. Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 11226-36. PMID 19741129 DOI: 10.1523/Jneurosci.6150-08.2009 |
0.36 |
|
| 2009 |
Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, Ma T, Zheng R, Lu B, Nanus DM, Lin MT, Gouras GK. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9704-13. PMID 19657023 DOI: 10.1523/Jneurosci.2292-09.2009 |
0.796 |
|
| 2007 |
Tsokas P, Ma T, Iyengar R, Landau EM, Blitzer RD. Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5885-94. PMID 17537959 DOI: 10.1523/Jneurosci.4548-06.2007 |
0.81 |
|
| 2006 |
Zimmermann HR, Yang W, Zhou X, Ma T. P2-157: BRAIN-SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P728-P728. DOI: 10.1016/J.Jalz.2018.06.844 |
0.433 |
|
| 2005 |
Tsokas P, Grace EA, Chan P, Ma T, Sealfon SC, Iyengar R, Landau EM, Blitzer RD. Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5833-43. PMID 15958750 DOI: 10.1523/Jneurosci.0599-05.2005 |
0.803 |
|
| Show low-probability matches. |